Journal of the Neurological Sciences
Volume 200, Issue 1 , Pages 43-48 , 15 August 2002

Gelatinase B, PECAM-1 and MCP-3 gene polymorphisms in Belgian multiple sclerosis

  • I Nelissen

      Affiliations

    • Rega Institute for Medical Research, Laboratory of Molecular Immunology, University of Leuven, Minderbroedersstraat 10, B-3000 Louvain, Belgium
    • ,
  • B Dubois

      Affiliations

    • University Hospital Gasthuisberg, Department of Neurology, University of Leuven, Louvain, Belgium
    • ,
  • A Goris

      Affiliations

    • Rega Institute for Medical Research, Laboratory of Molecular Immunology, University of Leuven, Minderbroedersstraat 10, B-3000 Louvain, Belgium
    • ,
  • I Ronsse

      Affiliations

    • Rega Institute for Medical Research, Laboratory of Molecular Immunology, University of Leuven, Minderbroedersstraat 10, B-3000 Louvain, Belgium
    • ,
  • H Carton

      Affiliations

    • University Hospital Gasthuisberg, Department of Neurology, University of Leuven, Louvain, Belgium
    • ,
  • G Opdenakker

      Affiliations

    • Rega Institute for Medical Research, Laboratory of Molecular Immunology, University of Leuven, Minderbroedersstraat 10, B-3000 Louvain, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: +32-16-33-73-41; fax: +32-16-33-73-40

Received 7 March 2002 ,Accepted 29 April 2002.

References 

  1. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens. 1991;38:1–15
  2. Nelissen I, Vandenbroeck K, Fiten P, et al.  Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis. J. Neuroimmunol. 2000;105:58–63
  3. Nelissen I, Fiten P, Vandenbroeck K, et al.  PECAM1, MPO and PRKAR1A at chromosome 17q21–q24 and susceptibility for multiple sclerosis in Sweden and Sardinia. J. Neuroimmunol. 2000;108:153–159
  4. Fiten P, Vandenbroeck K, Dubois B, et al.  Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development. J. Neuroimmunol. 1999;95:195–201
  5. Opdenakker G, Van den Steen P, Dubois B, et al.  Gelatinase B functions as regulator and effector in leukocyte biology. J. Leukoc. Biol. 2001;69:851–859
  6. Gijbels K, Masure S, Carton H, Opdenakker G. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J. Neuroimmunol. 1992;41:29–34
  7. Paemen L, Olsson T, Söderström M, Van Damme J, Opdenakker G. Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases. Eur. J. Neurol. 1994;1:55–63
  8. Proost P, Van Damme J, Opdenakker G. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. Biochem. Biophys. Res. Commun. 1993;192:1175–1181
  9. Cuzner ML, Gveric D, Strand C, et al.  The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J. Neuropathol. Exp. Neurol. 1996;55:1194–1204
  10. Maeda A, Sobel RA. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 1996;55:300–309
  11. Cossins JA, Clements JM, Ford J, et al.  Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol. Berl. 1997;94:590–598
  12. Newman PJ. The biology of PECAM-1. J. Clin. Invest. 1997;99:3–8
  13. Rival Y, Del Maschio A, Rabiet MJ, Dejana E, Duperray A. Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-alpha and IFN-gamma. J. Immunol. 1996;157:1233–1241
  14. Romer LH, McLean NV, Yan HC, Daise M, Sun J, DeLisser HM. IFN-gamma and TNF-alpha induce redistribution of PECAM-1 (CD31) on human endothelial cells. J. Immunol. 1995;154:6582–6592
  15. Stewart RJ, Kashxur TS, Marsden PA. Vascular endothelial platelet endothelial adhesion molecule-1 (PECAM-1) expression is decreased by TNF-alpha and IFN-gamma. Evidence for cytokine-induced destabilization of messenger ribonucleic acid transcripts in bovine endothelial cells. J. Immunol. 1996;156:1221–1228
  16. Tang Q, Hendricks RL. Interferon gamma regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas. J. Exp. Med. 1996;184:1435–1447
  17. Losy J, Niezgoda A, Wender M. Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions. J. Neuroimmunol. 1999;99:169–172
  18. Kuokkanen S, Gschwend M, Rioux JD, et al.  Genomewide scan of multiple sclerosis in Finnish multiplex families. Am. J. Hum. Genet. 1997;61:1379–1387
  19. Sawcer S, Jones HB, Feakes R, et al.  A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat. Genet. 1996;13:464–468
  20. Chataway J, Sawcer S, Feakes R, et al.  A screen of candidates from peaks of linkage: evidence for the involvement of myeloperoxidase in multiple sclerosis. J. Neuroimmunol. 1999;98:208–213
  21. Larsen F, Oturai A, Ryder LP, et al.  Linkage analysis of a candidate region in Scandinavian sib pairs with multiple sclerosis reveals linkage to chromosome 17q. Genes Immun. 2000;1:456–459
  22. Opdenakker G, Fiten P, Nys G, et al.  The human MCP-3 gene (SCYA7): cloning, sequence analysis, and assignment to the C–C chemokine gene cluster on chromosome 17q11.2–q12. Genomics. 1994;21:403–408
  23. Naruse K, Ueno M, Satoh T, et al.  A YAC contig of the human CC chemokine genes clustered on chromosome 17q11.2. Genomics. 1996;34:236–240
  24. Van Damme J, Proost P, Lenaerts JP, Opdenakker G. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J. Exp. Med. 1992;176:59–65
  25. Taub DD, Proost P, Murphy WJ, et al.  Monocyte chemotactic protein-1 (MCP-1), -2, and-3 are chemotactic for human T lymphocytes. J. Clin. Invest. 1995;95:1370–1376
  26. McManus C, Berman JW, Brett FM, Staunton H, Farrell M, Brosnan CF. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J. Neuroimmunol. 1998;86:20–29
  27. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 1993;52:506–516
  28. Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage disequilibrium and association. Am. J. Hum. Genet. 1996;59:983–989
  29. Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs. Holm methods. Am. J. Public Health. 1996;86:726–728
  30. Huhtala P, Tuuttila A, Chow LT, Lohi J, Keski OJ, Tryggvason K. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J. Biol. Chem. 1991;266:16485–16490
  31. Shimajiri S, Arima N, Tanimoto A, et al.  Shortened microsatellite d(CA)21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene. FEBS Lett. 1999;455:70–74
  32. Peters DG, Kassam A, St. Jean PL, Yonas H, Ferrell RE. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke. 1999;30:2612–2616
  33. St. Jean P, Zhang XC, Hart BK, et al.  Characterization of a dinucleotide repeat in the 92 kDa type IV collagenase gene (CLG4B), localization of CLG4B to chromosome 20 and the role of CLG4B in aortic aneurysmal disease. Ann. Hum. Genet. 1995;59:17–24
  34. Sciacca FL, Ferri C, D'Alfonso S, et al.  Association study of a new polymorphism in the PECAM-1 gene in multiple sclerosis. J. Neuroimmunol. 2000;104:174–178
  35. Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J. Neuroimmunol. 1998;84:238–249
  36. Sorensen TL, Tani M, Jensen J, et al.  Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 1999;103:807–815
  37. Van Der Voorn P, Tekstra J, Beelen RH, Tensen CP, Van der Valk P, De Groot CJ. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. Am. J. Pathol. 1999;154:45–51
  38. Thomson G. Mapping disease genes: family-based association studies. Am. J. Hum. Genet. 1995;57:487–498

PII: S0022-510X(02)00129-6

Journal of the Neurological Sciences
Volume 200, Issue 1 , Pages 43-48 , 15 August 2002

Article Tools